878 related articles for article (PubMed ID: 28733097)
21. Medication Treatment of Opioid Use Disorder.
Bell J; Strang J
Biol Psychiatry; 2020 Jan; 87(1):82-88. PubMed ID: 31420089
[TBL] [Abstract][Full Text] [Related]
22. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
[TBL] [Abstract][Full Text] [Related]
23. Prescribing decisions at buprenorphine treatment initiation: Do they matter for treatment discontinuation and adverse opioid-related events?
Meinhofer A; Williams AR; Johnson P; Schackman BR; Bao Y
J Subst Abuse Treat; 2019 Oct; 105():37-43. PubMed ID: 31443889
[TBL] [Abstract][Full Text] [Related]
24. Trends in pharmacy-based dispensing of buprenorphine, extended-release naltrexone, and naloxone during the COVID-19 pandemic by age and sex - United States, March 2019 - December 2020.
Cremer LJ; Board A; Guy GP; Schieber L; Asher A; Parker EM
Drug Alcohol Depend; 2022 Mar; 232():109192. PubMed ID: 35065513
[TBL] [Abstract][Full Text] [Related]
25. Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events.
Xu KY; Presnall N; Mintz CM; Borodovsky JT; Bhat NR; Bierut LJ; Grucza RA
JAMA Netw Open; 2021 Feb; 4(2):e210061. PubMed ID: 33625511
[TBL] [Abstract][Full Text] [Related]
26. Out-of-pocket spending and health care utilization associated with initiation of different medications for opioid use disorder: Findings from a national commercially insured cohort.
McCann NC; LaRochelle MR; Morgan JR
J Subst Use Addict Treat; 2024 Apr; 159():209281. PubMed ID: 38122988
[TBL] [Abstract][Full Text] [Related]
27. Racial Inequality in Receipt of Medications for Opioid Use Disorder.
Barnett ML; Meara E; Lewinson T; Hardy B; Chyn D; Onsando M; Huskamp HA; Mehrotra A; Morden NE
N Engl J Med; 2023 May; 388(19):1779-1789. PubMed ID: 37163624
[TBL] [Abstract][Full Text] [Related]
28. Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial.
Shulman M; Provost S; Ohrtman K; Novo P; Meyers-Ohki S; Van Veldhuisen P; Oden N; Otterstatter M; Bailey GL; Liu D; Rotrosen J; Nunes EV; Weiss RD
Contemp Clin Trials; 2024 Jul; 142():107543. PubMed ID: 38657730
[TBL] [Abstract][Full Text] [Related]
29. Trajectory classes of opioid use among individuals in a randomized controlled trial comparing extended-release naltrexone and buprenorphine-naloxone.
Ruglass LM; Scodes J; Pavlicova M; Campbell ANC; Fitzpatrick S; Barbosa-Leiker C; Burlew K; Greenfield SF; Rotrosen J; Nunes EV
Drug Alcohol Depend; 2019 Dec; 205():107649. PubMed ID: 31704382
[TBL] [Abstract][Full Text] [Related]
30. Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?
Grove LR; Rao N; Domino ME
Addiction; 2022 Nov; 117(11):2855-2863. PubMed ID: 35194878
[TBL] [Abstract][Full Text] [Related]
31. Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder.
Wang L; Volkow ND; Berger NA; Davis PB; Kaelber DC; Xu R
J Clin Psychol; 2023 Dec; 79(12):2869-2883. PubMed ID: 37584532
[TBL] [Abstract][Full Text] [Related]
32. Long-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health Administration.
Kelly MM; Reilly E; Quiñones T; Desai N; Rosenheck R
Drug Alcohol Depend; 2018 Feb; 183():111-117. PubMed ID: 29245103
[TBL] [Abstract][Full Text] [Related]
33. Dental care utilization in Massachusetts before and after initiation of medication for opioid use disorder: A cross-sectional study of a state all-payer claims database.
Simon L; Choudhary A; Ticku S; Barrow J; Tobey M
J Public Health Dent; 2022 Sep; 82(4):461-467. PubMed ID: 34816438
[TBL] [Abstract][Full Text] [Related]
34. Treating opioid use disorder with rapid micro induction technique of sublingual buprenorphine/naloxone in an outpatient setting-a case report.
Martell JP; Konakanchi JS; Sethi R
J Addict Dis; 2022; 40(3):439-443. PubMed ID: 35072589
[TBL] [Abstract][Full Text] [Related]
35. An alternative analysis of illicit opioid use during treatment in a randomized trial of extended-release naltrexone versus buprenorphine-naloxone: A per-protocol and completers analysis.
Mitchell MM; Schwartz RP; Choo TH; Pavlicova M; O'Grady KE; Gryczynski J; Stitzer ML; Nunes EV; Rotrosen J
Drug Alcohol Depend; 2021 Feb; 219():108422. PubMed ID: 33352487
[TBL] [Abstract][Full Text] [Related]
36. 48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method.
Azar P; Wong JSH; Mathew N; Vogel M; Perrone J; Herring AA; Krausz RM; Montaner JSG; Greenwald MK; Maharaj AR
J Addict Med; 2023 Mar-Apr 01; 17(2):233-236. PubMed ID: 36149002
[TBL] [Abstract][Full Text] [Related]
37. Does XR injectable naltrexone prevent relapse as effectively as daily sublingual buprenorphine-naloxone?
Roe M; Wilson CG; Fusco CW; Hulkower S; Stigleman S
J Fam Pract; 2020 Dec; 69(10):E14-E15. PubMed ID: 33348352
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial.
Tanum L; Solli KK; Latif ZE; Benth JŠ; Opheim A; Sharma-Haase K; Krajci P; Kunøe N
JAMA Psychiatry; 2017 Dec; 74(12):1197-1205. PubMed ID: 29049469
[TBL] [Abstract][Full Text] [Related]
39. Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials.
Baxley C; Borsari B; Reavis JV; Manuel JK; Herbst E; Becker W; Pennington D; Batki SL; Seal K
Addict Behav; 2023 Apr; 139():107589. PubMed ID: 36565531
[TBL] [Abstract][Full Text] [Related]
40. The Affordable Care Act In The Heart Of The Opioid Crisis: Evidence From West Virginia.
Saloner B; Landis R; Stein BD; Barry CL
Health Aff (Millwood); 2019 Apr; 38(4):633-642. PubMed ID: 30933592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]